NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
June 22, 2004 • Volume 1 / Number 25 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Featured Article

President Announces New NCAB Appointees

On June 18, the White House announced the appointment of five individuals to the National Cancer Advisory Board (NCAB) for 6-year terms that will expire March 9, 2010. The appointees are: Dr. John E. Niederhuber (who will also serve as chairman-designate for a 2-year term), Ms. Kathryn Giusti, Dr. Diana M. Lopez, Dr. Carolyn D. Runowicz, and Dr. Daniel Von Hoff.

NCAB, an advisory board mandated as part of the Public Health Service Act, advises the Secretary of the U.S. Department of Health and Human Services (HHS) and the Director of the National Cancer Institute (NCI) about the institute's activities. This includes reviewing and recommending for support grants and cooperative agreements following technical and scientific peer review.

NCAB consists of 18 members appointed by the President and includes leading representatives of the health and scientific disciplines; the general public, including leaders in fields of public policy, law, health policy, economics, and management; and experts in environmental carcinogenesis. In addition, leaders of several federal health agencies participate as nonvoting members.

Of the new appointees, Dr. Niederhuber is the only individual who is a current NCAB member. Dr. Niederhuber, who was originally appointed to NCAB in 2002, has been re-appointed to serve as chair for an additional 2 years. He is a professor of surgery and oncology at the University of Wisconsin Medical School.

Ms. Giusti is president of the Multiple Myeloma Research Foundation (MMRF), which she co-founded in 1998 after her own diagnosis of multiple myeloma. MMRF has raised more than $27 million for blood cancer research. In 2003, Ms. Giusti founded the Multiple Myeloma Research Consortium.

Dr. Lopez is a professor in the Department of Microbiology and Immunology at the University of Miami School of Medicine, and is also a program leader in tumor immunology in the Sylvester Comprehensive Cancer Center at the University of Miami School of Medicine. Dr. Lopez was also co-chair of the Trans-HHS Cancer Health Disparities Progress Review Group.

Dr. Runowicz is currently a professor in the Department of Obstetrics and Gynecology and director of the UConn Comprehensive Cancer Center of the University of Connecticut Health Center. Dr. Runowicz is a member of several professional societies and has been the recipient of many honors and awards throughout her medical career.

Dr. Von Hoff is director of the Arizona Health Science Center's Cancer Therapeutics Program, as well as professor in several departments of the University Medical Center in Tucson. Dr. Von Hoff has been a member of many societies, editorial boards, and committees throughout his distinguished career.

"The National Cancer Program will benefit tremendously from the expertise of these individuals," said NCI Director Dr. Andrew C. von Eschenbach. "Through the combination of these appointees' education, experience, and personal knowledge across the spectrum of cancer research, treatment, and survivorship, I am confident that the NCAB will continue to provide NCI with the best guidance to help meet our goal of eliminating the suffering and death due to cancer."